Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Special Drug Use-Results Survey of Gonalef (Subcutaneous injection 75/150, Subcutaneous injection pen 300/450/900) for Induction of Spermatogenesis in Male Hypogonadotropic Hypogonadism Patients

Trial Profile

Special Drug Use-Results Survey of Gonalef (Subcutaneous injection 75/150, Subcutaneous injection pen 300/450/900) for Induction of Spermatogenesis in Male Hypogonadotropic Hypogonadism Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2018

At a glance

  • Drugs Follitropin alfa (Primary)
  • Indications Male infertility
  • Focus Adverse reactions
  • Sponsors Merck Serono
  • Most Recent Events

    • 17 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top